title: Future perspectives: Moving towards NCL treatments.
abstract: Clinicians, basic researchers, representatives from pharma and families from around the world met in Cordoba, Argentina in October, 2014 to discuss recent research progress at the 14th International Congress on Neuronal Ceroid Lipofuscinoses (NCLs; Batten disease), a group of clinically overlapping fatal, inherited lysosomal disorders with primarily neurodegenerative symptoms. This brief review article will provide perspectives on the anticipated future directions of NCL basic and clinical research as we move towards improved diagnosis, care and treatment of NCL patients. This article is part of a Special Issue entitled: Current Research on the Neuronal Ceroid Lipofuscinoses (Batten Disease).
authors: Center for Human Genetic Research and Department of Neurology, Harvard Medical School, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. Electronic address: cotman@helix.mgh.harvard.edu.
authors: Susan L
authors: SL
authors: Cotman
authors: MRC Laboratory for Cell Biology, Department of Genetics, Evolution & Environment, UCL Institute of Child Health, University College London, Gower St, London, WC1E 6BT, UK.
authors: Sara E
authors: SE
authors: Mole
authors: Centro de Estudio de las Metabolopatías Congénitas (CEMECO), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba. Ferroviarios 1250, (5014) Córdoba, Argentina.
authors: Romina
authors: R
authors: Kohan
keywords: Batten disease; Neuronal Ceroid Lipofuscinosis (NCL)